Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page
- ChecktodayChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange Detected- Added the term CD4+/CD56+ hematodermic neoplasm to the study's keywords/MeSH terms.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a backend/UI framework update with no changes to study content or user interactions.SummaryDifference0.0%

Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.